HeraMED (STU:1I4) FCF Margin %: -1,124.14% (As of Dec. 2025)


What is HeraMED FCF Margin %?

HeraMED STU:1I4 +5.00% FCF Margin % is -1,124.14% as of Dec. 2025. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, HeraMED ranks worse than 95.09% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. HeraMED's Free Cash Flow for the six months ended in Dec. 2025 was €-0.98 Mil. HeraMED's Revenue for the six months ended in Dec. 2025 was €0.09 Mil. Therefore, HeraMED's FCF Margin % for the quarter that ended in Dec. 2025 was -1,124.14%.

As of today, HeraMED's current FCF Yield % is -8.31%.

The historical rank and industry rank for HeraMED's FCF Margin % or its related term are showing as below:

STU:1I4' s FCF Margin % Range Over the Past 10 Years
Min: -7258.82   Med: -1749.53   Max: -943.15
Current: -1254.55

During the past 8 years, the highest FCF Margin % of HeraMED was -943.15%. The lowest was -7258.82%. And the median was -1749.53%.

STU:1I4's FCF Margin % is ranked worse than
95.09% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.34 vs STU:1I4: -1254.55

HeraMED FCF Margin % Related Terms

HeraMED FCF Margin % Historical Data

* Premium members only.

The historical data trend for HeraMED's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeraMED FCF Margin % Chart

HeraMED Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -3,811.84 -1,485.37 -942.42 -1,323.64 -1,250.60

HeraMED Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,043.18 -1,516.96 -1,154.05 -1,400.00 -1,124.14

STU:1I4 vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, HeraMED's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeraMED FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeraMED's FCF Margin % distribution charts can be found below:

* The bar in red indicates where HeraMED's FCF Margin % falls into.


HeraMED FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

HeraMED's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-2.076/0.166
=-1,250.60 %

HeraMED's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.978/0.087
=-1,124.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -1,124.14% mean?
HeraMED (STU:1I4) has a FCF Margin % of -1,124.14% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on HeraMED and its competitors. According to the industry distribution chart, HeraMED ranks #775 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 95.1%.
Is HeraMED's FCF Margin % too high?
HeraMED's current FCF Margin % is -1,124.14%. Based on the distribution chart, HeraMED ranks #775 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does HeraMED's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HeraMED ranks #775 out of 815 companies for FCF Margin %. This places HeraMED in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on HeraMED and its competitors. HeraMED's current FCF Margin % is -1,124.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeraMED stock overvalued right now?
Based on GuruFocus' analysis, HeraMED (STU:1I4) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.01, compared to a current price of €0.02 — trading 110% above its estimated fair value. The current FCF Margin % is -1,124.14%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For HeraMED (STU:1I4), the current FCF Margin % is -1,124.14% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeraMED Business Description

Other Exchanges 1I4:GermanyHMD:Australia
Address 117 Camberwell Road, Level 1 - Suite 1, Hawthorn East, Melbourne, VIC, AUS, 3123
HeraMED Ltd is a medical data and technology company providing the digital transformation of maternity care by revolutionizing the prenatal and postpartum experience with its hybrid maternity care platform. It offers a proprietary platform that utilizes hardware and software to reshape the Doctor/Patient relationship using its clinically validated in-home foetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence. Its offering, HeraCARE, has been engineered to offer a fully integrated maternal health ecosystem designed to deliver care at a lower cost, ensure expectant mothers are engaged, informed and well-supported, and allow healthcare professionals to provide the care and enable early detection and prevention of potential risks.